178 related articles for article (PubMed ID: 30255549)
21. Phosphoribosylpyrophosphate synthesis in cultured human cells.
Benke PJ; Dittmar D
Science; 1977 Dec; 198(4322):1171-3. PubMed ID: 201027
[TBL] [Abstract][Full Text] [Related]
22. Down-Regulation of Phosphoribosyl Pyrophosphate Synthetase 1 Inhibits Neuroblastoma Cell Proliferation.
Li J; Ye J; Zhu S; Cui H
Cells; 2019 Aug; 8(9):. PubMed ID: 31443513
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle regulation of purine synthesis by phosphoribosyl pyrophosphate and inorganic phosphate.
Fridman A; Saha A; Chan A; Casteel DE; Pilz RB; Boss GR
Biochem J; 2013 Aug; 454(1):91-9. PubMed ID: 23734909
[TBL] [Abstract][Full Text] [Related]
24. Mutation in the phosphoribosylpyrophosphate synthetase gene (prs) that results in simultaneous requirements for purine and pyrimidine nucleosides, nicotinamide nucleotide, histidine, and tryptophan in Escherichia coli.
Hove-Jensen B
J Bacteriol; 1988 Mar; 170(3):1148-52. PubMed ID: 2449419
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a Salmonella typhimurium mutant defective in phosphoribosylpyrophosphate synthetase.
Jochimsen BU; Hove-Jensen B; Garber BB; Gots JS
J Gen Microbiol; 1985 Feb; 131(2):245-52. PubMed ID: 2580045
[TBL] [Abstract][Full Text] [Related]
26. Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic neuropathy (cmtx5).
Kim HJ; Sohn KM; Shy ME; Krajewski KM; Hwang M; Park JH; Jang SY; Won HH; Choi BO; Hong SH; Kim BJ; Suh YL; Ki CS; Lee SY; Kim SH; Kim JW
Am J Hum Genet; 2007 Sep; 81(3):552-8. PubMed ID: 17701900
[TBL] [Abstract][Full Text] [Related]
27. Additive reductions in zebrafish PRPS1 activity result in a spectrum of deficiencies modeling several human PRPS1-associated diseases.
Pei W; Xu L; Varshney GK; Carrington B; Bishop K; Jones M; Huang SC; Idol J; Pretorius PR; Beirl A; Schimmenti LA; Kindt KS; Sood R; Burgess SM
Sci Rep; 2016 Jul; 6():29946. PubMed ID: 27425195
[TBL] [Abstract][Full Text] [Related]
28. Accelerated transcription of PRPS1 in X-linked overactivity of normal human phosphoribosylpyrophosphate synthetase.
Ahmed M; Taylor W; Smith PR; Becker MA
J Biol Chem; 1999 Mar; 274(11):7482-8. PubMed ID: 10066814
[TBL] [Abstract][Full Text] [Related]
29. Early mitogenic stimulation of metabolic flux through phosphoribosyl pyrophosphate into nucleotides in Swiss 3T3 cells and requirement of external magnesium for the response.
Tatibana M; Ishijima S; Kita K; Ishizuka T; Suzuki N
Adv Enzyme Regul; 1989; 28():147-66. PubMed ID: 2483026
[TBL] [Abstract][Full Text] [Related]
30. Metabolic interaction between amino acid deprivation and cisplatin synergistically reduces phosphoribosyl-pyrophosphate and augments cisplatin cytotoxicity.
Wahwah N; Dhar D; Chen H; Zhuang S; Chan A; Casteel DE; Kalyanaraman H; Pilz RB; Boss GR
Sci Rep; 2020 Nov; 10(1):19907. PubMed ID: 33199755
[TBL] [Abstract][Full Text] [Related]
31. [PRPP synthetase deficiency].
Imaeda H; Wada Y
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):435-7. PubMed ID: 9590093
[No Abstract] [Full Text] [Related]
32. Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine riboside: optimization of 6-methylmercaptopurine riboside dose and schedule through biochemical analysis of sequential tumor biopsy specimens.
O'Dwyer PJ; Hudes GR; Colofiore J; Walczak J; Hoffman J; LaCreta FP; Comis RL; Martin DS; Ozols RF
J Natl Cancer Inst; 1991 Sep; 83(17):1235-40. PubMed ID: 1714507
[TBL] [Abstract][Full Text] [Related]
33. [Factors altering purine metabolism in liver cells].
Lalanne M; Des Rosiers C; Willemot J
Rev Can Biol Exp; 1982 Mar; 41(1):65-71. PubMed ID: 6179131
[TBL] [Abstract][Full Text] [Related]
34. PRPS2 mutations drive acute lymphoblastic leukemia relapse through influencing PRPS1/2 hexamer stability.
Song L; Li P; Sun H; Ding L; Wang J; Li B; Zhou BS; Feng H; Li Y
Blood Sci; 2023 Jan; 5(1):39-50. PubMed ID: 36742181
[TBL] [Abstract][Full Text] [Related]
35. Phosphoribosyl pyrophosphate, pool size and tissue levels as a determinant of 5-fluorouracil response in murine colonic adenocarcinomas.
Ardalan B; Villacorte D; Heck D; Corbett T
Biochem Pharmacol; 1982 Jun; 31(11):1989-92. PubMed ID: 6180752
[No Abstract] [Full Text] [Related]
36. Loss-of-function mutations in the PRPS1 gene cause a type of nonsyndromic X-linked sensorineural deafness, DFN2.
Liu X; Han D; Li J; Han B; Ouyang X; Cheng J; Li X; Jin Z; Wang Y; Bitner-Glindzicz M; Kong X; Xu H; Kantardzhieva A; Eavey RD; Seidman CE; Seidman JG; Du LL; Chen ZY; Dai P; Teng M; Yan D; Yuan H
Am J Hum Genet; 2010 Jan; 86(1):65-71. PubMed ID: 20021999
[TBL] [Abstract][Full Text] [Related]
37. Elucidation of pathways of 5-fluorouracil metabolism in xenografts of human colorectal adenocarcinoma.
Houghton JA; Houghton PJ
Eur J Cancer Clin Oncol; 1983 Jun; 19(6):807-15. PubMed ID: 6191988
[TBL] [Abstract][Full Text] [Related]
38. Cyclic AMP decreases the availability of 5-phosphoribosyl-1-pyrophosphate and decelerates de novo purine synthesis in rat hepatocytes.
Boer P; Giler S; Sperling O
Life Sci; 1998; 62(23):2133-9. PubMed ID: 9627092
[TBL] [Abstract][Full Text] [Related]
39. Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells.
Chen TL; Erlichman C
Cancer Chemother Pharmacol; 1992; 30(5):370-6. PubMed ID: 1380407
[TBL] [Abstract][Full Text] [Related]
40. [Purine metabolism: determination of PRPP-amidotransferase and PRPP-synthetase in lymphocytes from patients with chronic lymphatic leukemia (CLL)].
Tabucchi A; Terzuoli L; Di Stefano A; Pizzichini M; Leoncini R; Dispensa E; Marinello E
Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1097-103. PubMed ID: 2560926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
